Met Life Investment Management, LLC Exact Sciences Corp Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 6,608 shares of EXAS stock, worth $465,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,608
Previous 6,042
9.37%
Holding current value
$465,533
Previous $417,000
33.09%
% of portfolio
0.0%
Previous 0.0%
Shares
45 transactions
Others Institutions Holding EXAS
# of Institutions
637Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.28 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.16 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.04 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$850 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$578 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...